Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Banner

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1972
Crystallographic studies of chicken triose phosphate isomeraseD W Banner, A C Bloomer, G A Petsko, et al.
The Journal of Biological Chemistry|May 9, 1998
Coagulation factor VII Gln100 --> Arg. Amino acid substitution at the epidermal growth factor 2-protease domain interface results in severely reduced tissue factor binding and procoagulant functionG Kemball-Cook, D J Johnson, O Takamiya, et al.
Proteins|August 1, 1995
Activation of blood coagulation factor VIIa with cleaved tissue factor extracellular domain and crystallization of the active complexD Kirchhofer, A Guha, Y Nemerson, et al.
Cell|May 7, 1993
Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activationD W Banner, A D'Arcy, W Janes, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 26, 1981
On the three-dimensional structure and catalytic mechanism of triose phosphate isomeraseT Alber, D W Banner, A C Bloomer, et al.
Nature|March 7, 1996
The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factorD W Banner, A D'Arcy, C Chène, et al.
Journal of Molecular Biology|January 20, 1993
Crystallization and preliminary crystallographic analysis of a TNF-beta-55 kDa TNF receptor complexA D'Arcy, D W Banner, W Janes, et al.
Journal of Medicinal Chemistry|June 1, 2001
2-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitorsC Apfel, D W Banner, D Bur, et al.
Journal of Medicinal Chemistry|November 11, 1994
Design and synthesis of potent and highly selective thrombin inhibitorsK Hilpert, J Ackermann, D W Banner, et al.
Journal of Medicinal Chemistry|July 6, 2000
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agentsC Apfel, D W Banner, D Bur, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1972
Crystallographic studies of chicken triose phosphate isomeraseD W Banner, A C Bloomer, G A Petsko, et al.
The Journal of Biological Chemistry|May 9, 1998
Coagulation factor VII Gln100 --> Arg. Amino acid substitution at the epidermal growth factor 2-protease domain interface results in severely reduced tissue factor binding and procoagulant functionG Kemball-Cook, D J Johnson, O Takamiya, et al.
Proteins|August 1, 1995
Activation of blood coagulation factor VIIa with cleaved tissue factor extracellular domain and crystallization of the active complexD Kirchhofer, A Guha, Y Nemerson, et al.
Cell|May 7, 1993
Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activationD W Banner, A D'Arcy, W Janes, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 26, 1981
On the three-dimensional structure and catalytic mechanism of triose phosphate isomeraseT Alber, D W Banner, A C Bloomer, et al.
Nature|March 7, 1996
The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factorD W Banner, A D'Arcy, C Chène, et al.
Journal of Molecular Biology|January 20, 1993
Crystallization and preliminary crystallographic analysis of a TNF-beta-55 kDa TNF receptor complexA D'Arcy, D W Banner, W Janes, et al.
Journal of Medicinal Chemistry|June 1, 2001
2-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitorsC Apfel, D W Banner, D Bur, et al.
Journal of Medicinal Chemistry|November 11, 1994
Design and synthesis of potent and highly selective thrombin inhibitorsK Hilpert, J Ackermann, D W Banner, et al.
Journal of Medicinal Chemistry|July 6, 2000
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agentsC Apfel, D W Banner, D Bur, et al.
Pageof 4